Alan Abdulla
Impact in
-
- Antibiotic Use and Resistance
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 31
- Antibiotics Pharmacokinetics and Efficacy 31
- Epidemiology 11
- Pneumonia and Respiratory Infections 10
- Co-authors
- Birgit C. P. Koch (33 shared papers)Tim M. J. Ewoldt (19 shared papers)Henrik Endeman (19 shared papers)Anouk E. Muller (17 shared papers)Nicole Hunfeld (14 shared papers)Soma Bahmany (6 shared papers)Brenda C. M. de Winter (11 shared papers)Diederik Gommers (7 shared papers)
- Journals
- Expert Opinion on Drug Metabolism & Toxicology (5 papers)Therapeutic Drug Monitoring (3 papers)Journal of Antimicrobial Chemotherapy (2 papers)BMC Infectious Diseases (2 papers)Antibiotics (2 papers)
- Partner nations
- NetherlandsBelgiumSwitzerland
In The Last Decade
Alan Abdulla
33 papers receiving 558 citations
Peers
Comparison fields: 5 of 65
- Applied Microbiology and Biotechnology 81
- Pharmacology 413
- Molecular Medicine 85
- Clinical Biochemistry 64
- Epidemiology 140
Countries citing papers authored by Alan Abdulla
This map shows the geographic impact of Alan Abdulla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Abdulla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Abdulla more than expected).
Fields of papers citing papers by Alan Abdulla
This network shows the impact of papers produced by Alan Abdulla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Abdulla. The network helps show where Alan Abdulla may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Abdulla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 94 | |
| 2 | 2022 | 70 | |
| 3 | 2020 | 67 | |
| 4 | 2017 | 67 | |
| 5 | 2021 | 40 | |
| 6 | 2022 | 36 | |
| 7 | 2020 | 27 | |
| 8 | 2021 | 22 | |
| 9 | 2023 | 14 | |
| 10 | 2022 | 12 | |
| 11 | 2021 | 11 | |
| 12 | 2023 | 11 | |
| 13 | 2022 | 10 | |
| 14 | 2022 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2021 | 7 | |
| 17 | 2023 | 6 | |
| 18 | 2023 | 6 | |
| 19 | 2023 | 6 | |
| 20 | 2015 | 6 |
About Alan Abdulla
Alan Abdulla is a scholar working on Pharmacology, Epidemiology, Clinical Biochemistry, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 35 papers that have together received 562 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (31 papers), Pneumonia and Respiratory Infections (10 papers), Antibiotic Use and Resistance (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), Antibiotic Resistance in Bacteria (4 papers), Analytical Methods in Pharmaceuticals (3 papers), Pharmaceutical Practices and Patient Outcomes (1 paper) and Patient Safety and Medication Errors (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (81 citations), Pharmacology (413 citations), Molecular Medicine (85 citations), Clinical Biochemistry (64 citations) and Epidemiology (140 citations). Alan Abdulla has collaborated with scholars based in Netherlands, Belgium and Switzerland. Frequent co-authors include Birgit C. P. Koch, Tim M. J. Ewoldt, Henrik Endeman, Anouk E. Muller, Nicole Hunfeld, Soma Bahmany, Brenda C. M. de Winter, Diederik Gommers, Teun van Gelder and Annemieke Dijkstra. Their work appears in journals such as Expert Opinion on Drug Metabolism & Toxicology, Therapeutic Drug Monitoring, Journal of Antimicrobial Chemotherapy, BMC Infectious Diseases and Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.